NCT06736184View on ClinicalTrials.gov

The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Kidney Disease on HemodialysisHypokalemiaHyperkalemiaMyocardial Injury

Interventions

DRUG

Sodium Zirconium Cyclosilicate (SZC)

5g/meal\*3meals/day

All Listed Sponsors

lead

Qianfoshan Hospital

OTHER